Class III
Ongoing
Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01
Why: Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
- Company
- Chiesi USA, Inc.
Cary, NC, United States - Reported
- Sep 9, 2026
- Recall started
- Aug 19, 2026
- Where sold
- MO, TN
- Amount
- 3,002 vials
- Full product description
- Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01
- Lots / codes affected
- Lot#: 1221973, Exp 3/24/2027
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.